XM tillhandahåller inte tjänster till personer bosatta i USA.

U.S. Adicet Bio, Exxon Mobil, Oracle



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Adicet Bio, Exxon Mobil, Oracle</title></head><body>

Sept 11 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adicet Bio, Exxon Mobil and Oracle, on Wednesday.


HIGHLIGHTS


* Adicet Bio Inc ACET.O: H.C. Wainwright cuts to neutral from buy

* Exxon Mobil XOM.N: Gerdes Energy Research raises to buy from neutral

* One Gas Inc OGS.N: Wells Fargo raises to overweight from equal weight

* Oracle Corp ORCL.N: Citigroup raises target price to $157 from $140

* Supernus Pharmaceuticals Inc SUPN.O: Piper Sandler cuts to neutral from overweight


Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.


* Academy Sports and Outdoors Inc ASO.O: Evercore ISI raises target price to $65 from $60

* Academy Sports and Outdoors Inc ASO.O: Jefferies cuts target price to $64 from $68

* Academy Sports and Outdoors Inc ASO.O: JP Morgan cuts target price to $52 from $53

* Academy Sports and Outdoors Inc ASO.O: TD Cowen raises target price to $56 from $54

* Academy Sports and Outdoors Inc ASO.O: Truist Securities raises target to $63 from $60

* Academy Sports and Outdoors Inc ASO.O: Wells Fargo raises target price to $51 from $46

* Adicet Bio Inc ACET.O: H.C. Wainwright cuts to neutral from buy

* Adobe Inc ADBE.O: Citigroup raises target price to $621 from $550

* AES Corp AES.N: Jefferies initiates coverage with buy rating; price target $20

* Ally Financial Inc ALLY.N: BofA Global Research cuts price objective to $37 from $46

* Ally Financial Inc ALLY.N: BTIG cuts target price to $44 from $51

* Ally Financial Inc ALLY.N: CFRA cuts target price by $12 to $41

* Ally Financial Inc ALLY.N: Morgan Stanley cuts target price to $45 from $49

* Ani Pharmaceuticals Inc ANIP.O: Truist Securities cuts target price to $60 from $80

* Ani Pharmaceuticals Inc ANIP.O: Truist Securities cuts to hold from buy

* Applovin Corp APP.O: BofA Global Research raises price objective to $120 from $100

* Aquestive Therapeutics Inc AQST.O: Leerink Partners raises target price to $10 from $8

* Arrivent Biopharma Inc AVBP.O: Citigroup raises target price to $36 from $30

* AT&T Inc T.N: Citigroup raises target price to $24 from $21

* Axon Enterprise Inc AXON.O: Baird raises target price to $400 from $360

* Badger Meter Inc BMI.N: Seaport Research Partners initiates coverage with buy rating

* Badger Meter Inc BMI.N: Seaport Research Partners initiates coverage with target $235

* Bank of America BAC.N: Piper Sandler cuts target price to $43 from $44

* Bankunited Inc BKU.N: Citigroup cuts target price to $39 from $42

* Beam Therapeutics Inc BEAM.O: Stifel raises target price to $69 from $66

* Bridgebio pharma Inc BBIO.O: Leerink Partners cuts target price to $48 from $54

* BXP Inc BXP.N: Scotiabank raises target price to $82 from $76

* BXP Inc BXP.N: Wells Fargo raises target price to $80 from $73

* Cable One Inc CABO.N: Moffettnathanson cuts target price to $500 from $525

* Camden National Corp CAC.O: KBW raises target price to $41 from $40

* Campbell Soup CPB.O: Deutsche Bank raises target price to $50 from $48

* Campbell Soup Co CPB.O: Bernstein raises target price to $55 from $50

* Campbell Soup Co CPB.O: JP Morgan raises target price to $57 from $55

* Campbell Soup Company CPB.O: Wells Fargo raises target price to $51 from $49

* Cantaloupe, Inc. CTLP.O: Craig-Hallum cuts target price to $11 from $13

* Centene Corp CNC.N: Jefferies cuts target price to $72 from $74

* Charter Communications Inc CHTR.O: Citigroup raises to neutral from sell

* Civitas Resources Inc CIVI.N: Piper Sandler cuts target price to $84 from $85

* Comerica Inc CMA.N: Piper Sandler raises target price to $58 from $52

* Connectone Bancorp Inc CNOB.O: Stephens raises target price to $29 from $26.5

* Copt Defense Properties CDP.N: Wells Fargo cuts target price to $32 from $33

* Cousins Properties Inc. CUZ.N: Wells Fargo raises target price to $31 from $26

* Danaher DHR.N: Deutsche Bank raises target price to $285 from $270

* Darden Restaurants Inc DRI.N: Raymond James raises target price to $170 from $160

* Dave & Buster'S Entertainment Inc PLAY.O: BMO cuts target price to $55 from $65

* Domino's Pizza Inc DPZ.N: BMO cuts target price to $510 from $525

* Doubleverify Holdings Inc DV.N: Canaccord Genuity cuts target price to $36 from $40

* Douglas Emmett, Inc. DEI.N: Wells Fargo raises target price to $17 from $15

* Empire State Realty Trust, Inc. ESRT.N: Wells Fargo raises target price to $10 from $7

* Exxon Mobil XOM.N: Gerdes Energy Research raises target price by $4 to $134

* Exxon Mobil XOM.N: Gerdes Energy Research raises to buy from neutral

* Factset FDS.N: Jefferies raises target price to $435 from $425

* Gamestop Corp GME.N: Wedbush cuts target price to $10 from $11

* Highwoods Properties, Inc. HIW.N: Wells Fargo raises target price to $32 from $22

* Hudson Pacific Properties, Inc. HPP.N: Wells Fargo cuts target price to $4.5 from $5

* IBM IBM.N: Evercore ISI raises target price to $240 from $215

* Intellia Therapeutics Inc NTLA.O: Stifel cuts target price to $64 from $80

* International Flavors & Fragrances IFF.N: Oppenheimer raises target to $117 from $116

* Janus International Group Inc JBI.N: Jefferies cuts target price to $12 from $15

* JP Morgan JPM.N: Piper Sandler cuts target price to $226 from $230

* Kilroy Realty Corporation KRC.N: Wells Fargo cuts target price to $38 from $39

* Kinder Morgan Inc KMI.N: UBS raises target price to $25 from $24

* Krystal Biotech Inc KRYS.O: Stifel raises target price to $220 from $204

* Lindblad Expeditions Holdings Inc LIND.O: Deutsche Bank raises target to $10 from $9

* Mama'S Creations Inc MAMA.O: Craig-Hallum raises target price to $10 from $9

* Marathon Digital Holdings Inc MARA.O: Jefferies cuts target price to $16 from $17

* Northeast Bank NBN.O: Piper Sandler assumes coverage with overweight rating; PT $80

* Norwegian Cruise Line NCLH.N: Mizuho raises target price to $26 from $25

* One Gas Inc OGS.N: Wells Fargo raises target price to $80 from $71

* One Gas Inc OGS.N: Wells Fargo raises to overweight from equal weight

* Oracle Corp ORCL.N: Citigroup raises target price to $157 from $140

* Pacs Group Inc PACS.N: Citigroup resumes coverage with buy rating; price target $45

* Paramount Group, Inc. PGRE.N: Wells Fargo raises target price to $4 from $3.5

* Parker-Hannifin Corp PH.N: TD Cowen raises target price to $520 from $500

* Petco Health and Wellness Co WOOF.O: RBC raises target price to $3.5 from $3

* Petco Health and Wellness Company, Inc. WOOF.O: Wells Fargo raises PT to $3 from $2.75

* Phillips 66 PSX.N: TD Cowen cuts target price to $150 from $162

* Rocket Companies Inc RKT.N: Wedbush raises target price to $18 from $15

* Rubrik Inc RBRK.N: Citigroup raises target price to $48 from $47

* Sirius XM Holdings Inc SIRI.O: Deutsche Bank adjusts PT to $28 from $3 to reflect completion of split-off and merger

* Sirius XM Holdings, Inc. SIRI.O: Wells Fargo cuts target price to $23 from $25

* SL Green Realty Corp. SLG.N: Wells Fargo raises target price to $63 from $43

* Supernus Pharmaceuticals Inc SUPN.O: Piper Sandler cuts target price to $36 from $41

* Supernus Pharmaceuticals Inc SUPN.O: Piper Sandler cuts to neutral from overweight

* Tenet Healthcare Corp THC.N: Raymond James raises target price to $195 from $175

* Tilray Brands Inc TLRY.O: Jefferies cuts target price to $2.5 from $3.19

* Triumph Group Inc TGI.N: JP Morgan cuts target price to $15 from $17

* Viking Therapeutics Inc VKTX.O: JP Morgan initiates coverage with overweight rating

* Viking Therapeutics Inc VKTX.O: JP Morgan initiates coverage with target price $80

* Viridian Therapeutics Inc VRDN.O: B. Riley raises target price to $22 from $20

* Viridian Therapeutics Inc VRDN.O: BTIG raises target price to $56 from $46

* Viridian Therapeutics Inc VRDN.O: Leerink Partners raises target price to $48 from $45

* Viridian Therapeutics Inc VRDN.O: Needham raises target price to $38 from $30

* Voya Financial Inc VOYA.N: Evercore ISI raises target price to $82 from $79

* Williams-Sonoma Inc WSM.N: Jefferies raises to buy from hold; raises PT to $156 from $148

* Zions Bancorporation Na ZION.O: Jefferies cuts target price to $49 from $51


(Compiled by Bengaluru Newsroom)

</body></html>

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.